GL1X · GenesisL1 explorer

MolNFT v1 · #184868 · protein

Variant surface glycoprotein 3 (VSG3, MITAT1.3, VSG224) mutant (serine 319 to alanine), single O-linked glycosylated at SER317

7P5B: “Variant surface glycoprotein 3 (VSG3, MITAT1.3, VSG224) mutant (serine 319 to alanine), single O-linked…”. X-ray diffraction, 4 ligands (MAN, NAG, BMA), 2 pockets (best druggability 0.37). MolNFT v1 #184868 on GenesisL1: 3D…

PDB
7P5B
Type
protein
Length
358 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Variant surface glycoprotein
UniProt
B3GVK1
Ligands
MAN, NAG, BMA, GLC
Pockets
2 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVariant surface glycoproteinprotein35853% helix, 4% strandB3GVK1

Ligands and binding sites

  • MAN · alpha-D-mannopyranose · sugar · 3 copies · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • BMA · beta-D-mannopyranose · sugar · chains A
  • GLC · alpha-D-glucopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1990.370.7514NAG
2500.230.7212empty

Modifications

Observed in the structure: 4 disulfide, 2 glycan (disulfide, N-glycosylation, O-glycosylation).

Compared structures

  • 7P5B · Variant Surface Glycoprotein 3 (VSG3, MiTat1.3, VSG224) mutant (serine 319 to alanine)… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.